Dr Reddys Laboratories (RDY) Share-based Compensation Growth (1y) (2010 - 2026)
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Share-based Compensation Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.90 Bn | 2.15 Bn | 5.26% |
| 2 | Viatris | 19.15 Bn | 18.27 Bn | 1.46 Bn | -18.06% |
| 3 | Dr Reddys Laboratories | 9.88 Bn | 9.71 Bn | 396.53 Mn | -21.71% |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn | -6.88% |
| 5 | Bausch Health Companies | 2.33 Bn | 496.37 Mn | 2.10 Bn | 17.39% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn | 18.79% |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | 12.69% |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | -17.19% |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -21.71% |
| Sep 30, 2025 | -10.26% |
| Jun 30, 2025 | 8.09% |
| Sep 30, 2024 | 2.53% |
| Jun 30, 2024 | -7.89% |
| Mar 31, 2024 | 357.22% |
| Dec 31, 2023 | -13.61% |
| Sep 30, 2023 | -15.09% |
| Jun 30, 2023 | -30.57% |
| Mar 31, 2023 | -86.38% |
| Dec 31, 2022 | -35.95% |
| Sep 30, 2022 | -23.96% |
| Jun 30, 2022 | -5.03% |
| Mar 31, 2022 | 5.99% |
| Dec 31, 2021 | 5.10% |
| Sep 30, 2021 | -10.72% |
| Jun 30, 2021 | 6.01% |
| Mar 31, 2021 | 5.06% |
| Dec 31, 2020 | 14.71% |
| Sep 30, 2020 | 12.04% |